Literature DB >> 16429447

Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system.

Divya M Chari1, Chao Zhao, Mark R Kotter, William F Blakemore, Robin J M Franklin.   

Abstract

High dose corticosteroid (CS) administration is a common mode of therapy in treatment of acute relapses in multiple sclerosis (MS) but the effects of CS on remyelination and the cellular mechanisms mediating this repair process are controversial. We have examined CS effects on repair of toxin-induced demyelinating lesions in the adult rat spinal cord. Corticosteroids reduced the extent of oligodendrocyte remyelination at 1 month post lesion (whereas Schwann-cell mediated repair was unaffected). However, CS did not cause permanent impairment of remyelination as lesions were fully remyelinated at 2 months after cessation of treatment. The delay in oligodendrocyte mediated repair could be attributed to inhibition of differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes, with no effect of CS treatment observed on OPC colonisation of the lesions. No differences were observed in animals treated with methylprednisolone succinate alone or with a subsequent prednisone taper indicating that CS effects occur at an early stage of repair. The potential consequences of delayed remyelination in inflammatory lesions are discussed. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16429447     DOI: 10.1002/jnr.20763

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

1.  Pubertal ovarian hormone exposure reduces the number of myelinated axons in the splenium of the rat corpus callosum.

Authors:  M A Yates; J M Juraska
Journal:  Exp Neurol       Date:  2007-10-25       Impact factor: 5.330

2.  Glucocorticoid-Induced Reductions of Myelination and Connexin 43 in Mixed Central Nervous System Cell Cultures Are Prevented by Mifepristone.

Authors:  José Javier Miguel-Hidalgo; Kathleen Carter; Preston Hardin Deloach; Leon Sanders; Yi Pang
Journal:  Neuroscience       Date:  2019-06-01       Impact factor: 3.590

3.  Impaired adult myelination in the prefrontal cortex of socially isolated mice.

Authors:  Jia Liu; Karen Dietz; Jacqueline M DeLoyht; Xiomara Pedre; Dipti Kelkar; Jasbir Kaur; Vincent Vialou; Mary Kay Lobo; David M Dietz; Eric J Nestler; Jeffrey Dupree; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2012-11-11       Impact factor: 24.884

4.  Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.

Authors:  Rashad Hussain; Martine El-Etr; Ouardia Gaci; Jennifer Rakotomamonjy; Wendy B Macklin; Narender Kumar; Regine Sitruk-Ware; Michael Schumacher; Abdel M Ghoumari
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

5.  The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.

Authors:  Dana M McTigue; Richa Tripathi; Ping Wei; A Todd Lash
Journal:  Exp Neurol       Date:  2007-02-27       Impact factor: 5.330

6.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 7.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

8.  Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.

Authors:  Daniella Urbach-Ross; Alexander W Kusnecov
Journal:  Brain Behav Immun       Date:  2007-05-08       Impact factor: 7.217

Review 9.  Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.

Authors:  Lyl Tomlinson; Cindy V Leiton; Holly Colognato
Journal:  Neuropharmacology       Date:  2015-09-28       Impact factor: 5.250

10.  Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy.

Authors:  Stuart I Jenkins; Mark R Pickard; Melinda Khong; Heather L Smith; Carl L A Mann; Richard D Emes; Divya M Chari
Journal:  ACS Chem Neurosci       Date:  2013-11-07       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.